Virtu Financial’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66K Buy
+14,479
New +$60.2K ﹤0.01% 1182
2024
Q3
Sell
-27,580
Closed -$40K 1990
2024
Q2
$40K Buy
+27,580
New +$51.1K ﹤0.01% 936
2023
Q4
Sell
-14,947
Closed -$72K 2104
2023
Q3
$72K Buy
+14,947
New +$86.9K 0.01% 874
2021
Q3
Sell
-3,125
Closed -$79K 2061
2021
Q2
$79K Sell
3,125
-2,362
-43% -$54K 0.01% 1255
2021
Q1
$106K Sell
5,487
-5,919
-52% -$136K 0.01% 1305
2020
Q4
$168K Buy
11,406
+8,943
+363% +$191K 0.02% 915
2020
Q3
$55K Buy
+2,463
New +$51.8K 0.01% 812
2019
Q4
$23K Buy
+2,470
New +$20.6K ﹤0.01% 1307

Other funds holding WHWK

Virtu Financial's WHWK Position: Q2 2026 in Review

Virtu Financial opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 14,479 shares worth $66K. The stake represents ﹤0.01% of the portfolio and ranks #1182 among its holdings. This is a return to the name: Virtu Financial previously reported a position in WHWK as recently as Q2 2024.

Virtu Financial first reported a position in WHWK in Q4 2019 and has held it in 8 quarters since. The position peaked at $168K in Q4 2020. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Virtu Financial held 14,479 shares of Whitehawk Therapeutics worth $66K as of Q2 2026.
  • Whitehawk Therapeutics was a new Virtu Financial position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1182 holding.
  • Virtu Financial first reported a position in Whitehawk Therapeutics in Q4 2019 and has held it in 8 quarters since.
  • Virtu Financial's Whitehawk Therapeutics position peaked at $168K in Q4 2020.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.